Cargando…

Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis

BACKGROUND: The incidence and etiologies of chronic pulmonary infection (CPI) in patients with idiopathic pulmonary fibrosis (IPF) have been poorly investigated. METHODS: We conducted a retrospective study of 659 patients with IPF to assess the incidence, etiologies, and risk factors of CPI developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Odashima, Kyuto, Kagiyama, Naho, Kanauchi, Tetsu, Ishiguro, Takashi, Takayanagi, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122739/
https://www.ncbi.nlm.nih.gov/pubmed/32243456
http://dx.doi.org/10.1371/journal.pone.0230746
_version_ 1783515483090190336
author Odashima, Kyuto
Kagiyama, Naho
Kanauchi, Tetsu
Ishiguro, Takashi
Takayanagi, Noboru
author_facet Odashima, Kyuto
Kagiyama, Naho
Kanauchi, Tetsu
Ishiguro, Takashi
Takayanagi, Noboru
author_sort Odashima, Kyuto
collection PubMed
description BACKGROUND: The incidence and etiologies of chronic pulmonary infection (CPI) in patients with idiopathic pulmonary fibrosis (IPF) have been poorly investigated. METHODS: We conducted a retrospective study of 659 patients with IPF to assess the incidence, etiologies, and risk factors of CPI development. CPI was defined if the etiology of infection was diagnosed one or more months after the onset of symptoms or upon the appearance of new shadows on pulmonary radiological images. RESULTS: At IPF diagnosis, 36 (5.5%) patients had CPI, and 46 (7.0%) patients without CPI at IPF diagnosis developed CPI over a median follow-up period of 6.1 years. The incidence density of CPI development was 18.90 cases per 1000 person-years. Detected organisms from these 46 patients were Mycobacterium avium complex in 20 patients, other nontuberculous mycobacteria in 4, M. tuberculosis in 7, Aspergillus spp. in 22, and Nocardia sp. in one. In a multivariate Cox regression hazard model, PaO(2) <70 Torr and KL-6 ≥2000 U/mL were associated with CPI development. CONCLUSIONS: Nontuberculous mycobacteria, M. tuberculosis, and Aspergillus and Nocardia spp. were the four most frequent etiologies of CPI in patients with IPF. During follow-up of IPF, clinicians should pay attention to the development of CPI, especially in patients with PaO(2) <70 Torr or KL-6 ≥2000 U/mL.
format Online
Article
Text
id pubmed-7122739
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-71227392020-04-09 Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis Odashima, Kyuto Kagiyama, Naho Kanauchi, Tetsu Ishiguro, Takashi Takayanagi, Noboru PLoS One Research Article BACKGROUND: The incidence and etiologies of chronic pulmonary infection (CPI) in patients with idiopathic pulmonary fibrosis (IPF) have been poorly investigated. METHODS: We conducted a retrospective study of 659 patients with IPF to assess the incidence, etiologies, and risk factors of CPI development. CPI was defined if the etiology of infection was diagnosed one or more months after the onset of symptoms or upon the appearance of new shadows on pulmonary radiological images. RESULTS: At IPF diagnosis, 36 (5.5%) patients had CPI, and 46 (7.0%) patients without CPI at IPF diagnosis developed CPI over a median follow-up period of 6.1 years. The incidence density of CPI development was 18.90 cases per 1000 person-years. Detected organisms from these 46 patients were Mycobacterium avium complex in 20 patients, other nontuberculous mycobacteria in 4, M. tuberculosis in 7, Aspergillus spp. in 22, and Nocardia sp. in one. In a multivariate Cox regression hazard model, PaO(2) <70 Torr and KL-6 ≥2000 U/mL were associated with CPI development. CONCLUSIONS: Nontuberculous mycobacteria, M. tuberculosis, and Aspergillus and Nocardia spp. were the four most frequent etiologies of CPI in patients with IPF. During follow-up of IPF, clinicians should pay attention to the development of CPI, especially in patients with PaO(2) <70 Torr or KL-6 ≥2000 U/mL. Public Library of Science 2020-04-03 /pmc/articles/PMC7122739/ /pubmed/32243456 http://dx.doi.org/10.1371/journal.pone.0230746 Text en © 2020 Odashima et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Odashima, Kyuto
Kagiyama, Naho
Kanauchi, Tetsu
Ishiguro, Takashi
Takayanagi, Noboru
Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis
title Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis
title_full Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis
title_fullStr Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis
title_full_unstemmed Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis
title_short Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis
title_sort incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122739/
https://www.ncbi.nlm.nih.gov/pubmed/32243456
http://dx.doi.org/10.1371/journal.pone.0230746
work_keys_str_mv AT odashimakyuto incidenceandetiologyofchronicpulmonaryinfectionsinpatientswithidiopathicpulmonaryfibrosis
AT kagiyamanaho incidenceandetiologyofchronicpulmonaryinfectionsinpatientswithidiopathicpulmonaryfibrosis
AT kanauchitetsu incidenceandetiologyofchronicpulmonaryinfectionsinpatientswithidiopathicpulmonaryfibrosis
AT ishigurotakashi incidenceandetiologyofchronicpulmonaryinfectionsinpatientswithidiopathicpulmonaryfibrosis
AT takayanaginoboru incidenceandetiologyofchronicpulmonaryinfectionsinpatientswithidiopathicpulmonaryfibrosis